Indaptus Therapeutics Inc (INDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2015 | 12-2014 | |
| Cash Flows From Operating Activities | ||
| Net Income | -2,789 | -5,110 |
| Depreciation Amortization | 252 | 520 |
| Other Working Capital | -927 | -40 |
| Other Operating Activity | 73 | 360 |
| Operating Cash Flow | $-3,391 | $-4,270 |
| Cash Flows From Investing Activities | ||
| Change In Deposits | -45 | N/A |
| PPE Investments | -833 | -60 |
| Other Investing Activity | 13 | 2,500 |
| Investing Cash Flow | $-865 | $2,440 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 1,844 | N/A |
| Other Financing Activity | -261 | 4,340 |
| Financing Cash Flow | $1,583 | $4,340 |
| Exchange Rate Effect | -18 | 130 |
| Beginning Cash Position | 5,731 | 2,950 |
| End Cash Position | 3,040 | 5,590 |
| Net Cash Flow | $-2,691 | $2,640 |
| Free Cash Flow | ||
| Operating Cash Flow | -3,391 | -4,270 |
| Capital Expenditure | -833 | N/A |
| Free Cash Flow | -4,224 | -4,270 |